Zhejiang Chimin Pharm Co Ltd (603222) - Total Assets
Based on the latest financial reports, Zhejiang Chimin Pharm Co Ltd (603222) holds total assets worth CN¥2.27 Billion CNY (≈ $331.94 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Zhejiang Chimin Pharm Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Zhejiang Chimin Pharm Co Ltd - Total Assets Trend (2011–2025)
This chart illustrates how Zhejiang Chimin Pharm Co Ltd's total assets have evolved over time, based on quarterly financial data. Explore 603222 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Zhejiang Chimin Pharm Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Zhejiang Chimin Pharm Co Ltd's total assets of CN¥2.27 Billion consist of 25.3% current assets and 74.7% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 12.8% |
| Accounts Receivable | CN¥115.82 Million | 5.0% |
| Inventory | CN¥112.69 Million | 4.9% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥193.38 Million | 8.4% |
| Goodwill | CN¥14.75 Million | 0.6% |
Asset Composition Trend (2011–2025)
This chart illustrates how Zhejiang Chimin Pharm Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Zhejiang Chimin Pharm Co Ltd (603222) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Zhejiang Chimin Pharm Co Ltd's current assets represent 25.3% of total assets in 2025, a decrease from 59.7% in 2011.
- Cash Position: Cash and equivalents constituted 12.8% of total assets in 2025, up from 4.7% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, a decrease from 14.0% in 2011.
- Asset Diversification: The largest asset category is intangible assets at 8.4% of total assets.
Zhejiang Chimin Pharm Co Ltd Competitors by Total Assets
Key competitors of Zhejiang Chimin Pharm Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Medline Inc. Class A Common Stock
NASDAQ:MDLN
|
USA | $39.01 Billion |
|
Warby Parker Inc
NYSE:WRBY
|
USA | $736.41 Million |
|
Touchstone International Medical Science Co Ltd
SHG:688013
|
China | CN¥676.02 Million |
|
Formosa Optical Technology Co Ltd
TWO:5312
|
Taiwan | NT$9.15 Billion |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.33 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$135.84 Million |
|
Austco Healthcare Ltd
AU:AHC
|
Australia | AU$91.07 Million |
Zhejiang Chimin Pharm Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.78 | 1.33 | 1.08 |
| Quick Ratio | 0.64 | 1.08 | 0.94 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥-153.75 Million | CN¥228.96 Million | CN¥71.91 Million |
Zhejiang Chimin Pharm Co Ltd - Advanced Valuation Insights
This section examines the relationship between Zhejiang Chimin Pharm Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.04 |
| Latest Market Cap to Assets Ratio | 0.23 |
| Asset Growth Rate (YoY) | -4.3% |
| Total Assets | CN¥2.31 Billion |
| Market Capitalization | $536.32 Million USD |
Valuation Analysis
Below Book Valuation: The market values Zhejiang Chimin Pharm Co Ltd's assets below their book value (0.23x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Zhejiang Chimin Pharm Co Ltd's assets decreased by 4.3% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Zhejiang Chimin Pharm Co Ltd (2011–2025)
The table below shows the annual total assets of Zhejiang Chimin Pharm Co Ltd from 2011 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥2.31 Billion ≈ $337.97 Million |
-4.34% |
| 2024-12-31 | CN¥2.41 Billion ≈ $353.30 Million |
-2.64% |
| 2023-12-31 | CN¥2.48 Billion ≈ $362.90 Million |
-8.62% |
| 2022-12-31 | CN¥2.71 Billion ≈ $397.15 Million |
+11.92% |
| 2021-12-31 | CN¥2.43 Billion ≈ $354.86 Million |
+5.81% |
| 2020-12-31 | CN¥2.29 Billion ≈ $335.39 Million |
+9.95% |
| 2019-12-31 | CN¥2.08 Billion ≈ $305.03 Million |
-1.90% |
| 2018-12-31 | CN¥2.12 Billion ≈ $310.93 Million |
+34.92% |
| 2017-12-31 | CN¥1.57 Billion ≈ $230.46 Million |
+70.74% |
| 2016-12-31 | CN¥922.43 Million ≈ $134.98 Million |
+9.29% |
| 2015-12-31 | CN¥844.01 Million ≈ $123.51 Million |
+33.96% |
| 2014-12-31 | CN¥630.04 Million ≈ $92.19 Million |
-11.68% |
| 2013-12-31 | CN¥713.38 Million ≈ $104.39 Million |
+3.29% |
| 2012-12-31 | CN¥690.63 Million ≈ $101.06 Million |
+5.39% |
| 2011-12-31 | CN¥655.30 Million ≈ $95.89 Million |
-- |
About Zhejiang Chimin Pharm Co Ltd
Chimin Health Management Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells vitro diagnostic products and provides medical services in China and internationally. The company provides non-PVC double-tube double-valve, single-tube single-valve, and single-tube double-valve soft bags; plastic bottles; and other packaging forms. It also offers medical instruments, in… Read more